http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_95e641f99ee1334ec875fff1628643bf
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Sodroski |
| name | Joseph Sodroski |
| given-name | Joseph |
| organization-name | Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA; Department of Microbiology, Harvard Medical School, Boston, Massachusetts, USA; Department of Immunology and Infectious Diseases, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, USA Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute; Department of Pathology; Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, Massachusetts 02115 1Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Department of Pathology, Division of AIDS, Harvard Medical School; 3Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, MA 02115 *Department of Cancer Immunology and AIDS, Dana–Farber Cancer Institute, Harvard Medical School Division of AIDS, Boston, MA 02115;; Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, MA 02115; and Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Division of AIDS, Harvard Medical School, Boston, Massachusetts 02115; Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, Massachusetts 02115 Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute; Department of Pathology, Division of AIDS, Harvard Medical School, and Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, Massachusetts 02115 Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA; Department of Microbiology, Harvard Medical School, Boston, Massachusetts, USA Division of Human Retrovirology, Dana-Farber Cancer Institute, Department of Pathology, Harvard Medical School,1; Department of Cancer Biology, Harvard School of Public Health,4 Boston, Massachusetts, and Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Boston, Massachusetts, USA; Department of Microbiology and Immunobiology, Harvard Medical School, Boston, Massachusetts, USA; Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, USA; Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, Massachusetts, USA Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, Department of Biology, The Johns Hopkins University, Baltimore, Maryland 21218, and Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute and Division of AIDS, Harvard Medical School, Boston, Massachusetts 02115 Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Department of Pathology, Division of AIDS, Harvard Medical School; Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, Massachusetts 02115 Department of Biology, The Johns Hopkins University, Baltimore, Maryland 21218, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115, and Department of Chemistry, University of Pennsylvania, Philadelphia, Pennsylvania 19104 Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Avenue, Boston, Massachusetts 02115, United States; Department of Microbiology and Immunology, Harvard Medical School, Department of Immunology and Infectious Diseases, Harvard School of Public Health, Ragon Institute of MGH, MIT and Harvard, Boston, Massachusetts 02115, United States Department of Cancer Immunology and Virology Dana-Farber Cancer Institute, Department of Microbiology and Immunobiology Harvard Medical School Boston MA 02115 USA Laboratory of Biochemical Pharmacology, Dana-Farber Cancer Institute, and Department of Pathology, Harvard Medical School, Boston, MA 02115. Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Division of AIDS, Harvard Medical School; Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, Massachusetts 02115 Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA; Department of Microbiology and Immunobiology, Harvard Medical School, Boston, Massachusetts, USA; Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA Department of Biochemistry, Drexel University College of Medicine, Philadelphia, Pennsylvania 19102, Division of Human Retrovirology, Dana-Farber Cancer Institute, Department of Pathology, Division of AIDS, Harvard Medical School, and Department of Cancer Biology, Harvard School of Public Health, Boston, Massachusetts 02115, GlaxoSmithKline, King of Prussia, Pennsylvania 19406, Department of Biology, Johns Hopkins University, Baltimore, Maryland 21218, and Departments of Immunology and Molecular Biology,... Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, and Department of Microbiology and Immunobiology, Division of AIDS, Harvard Medical School, Boston, Massachusetts, USA; Department of Immunology and Infectious Diseases, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, USA K. A. Martin, Perlmutter Laboratory, Children's Hospital, Department of Medicine, Harvard Medical School, Boston, MA 02115, USA.; R. Wyatt, M. Farzan, H. Choe, E. Desjardins, Division of Human Retrovirology, Dana-Farber Cancer Institute and Department of Pathology, Harvard Medical School, Boston, MA 02115, USA.; L. Marcon, Division of Human Retrovirology, Dana-Farber Cancer Institute and Department of Pathology, Harvard Medical School, Boston, MA 02115, USA, and Institute of Microbiology, University of Padua Medical School, Padua 35121, Italy.; J. Sodroski, Division of Human Retrovirology, Dana-Farber Cancer Institute and Department of Pathology, Harvard Medical School, and Department of Cancer Biology, Harvard School of Public Health, Boston, MA 02115, USA.; J. Robinson, Department of Pediatrics, Tulane University Medical Center, 1430 Tulane Avenue, New Orleans, LA 70112, USA. Division of Human Retrovirology, Dana-Farber Cancer Institute,1; Department of Cancer Biology, Harvard School of Public Health,6 and Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115, United States; Department of Microbiology and Immunobiology, Harvard Medical School; Department of Immunology and Infectious Diseases, Harvard School of Public Health; Ragon Institute of MGH, MIT, and Harvard, Boston, Massachusetts 02115, United States C. D. Rizzuto, R. Wyatt, N. Hernández-Ramos, Y. Sun, Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Department of Pathology, Harvard Medical School, Boston, MA 02115, USA.; P. D. Kwong and W. A. Hendrickson, Department of Biochemistry and Molecular Biophysics, Howard Hughes Medical Institute, Columbia University, New York, NY 10032, USA.; J. Sodroski, Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Department of Pathology, Harvard Medical School, and Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, MA 02115, USA. Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute; Department of Microbiology, Harvard Medical School, Boston, Massachusetts, USA Department of Immunology Cancer and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA; Department of Microbiology and Immunobiology, Harvard Medical School, Boston, Massachusetts, USA; Department of Immunology and Infectious Diseases, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, USA Department of Biochemistry and Molecular Biology, Drexel University College of Medicine, Philadelphia, Pennsylvania 19102, Department of Microbiology and Immunology and Center for Molecular Therapeutics, Institute for Molecular Medicine and Infectious Disease, Drexel University College of Medicine, Philadelphia, Pennsylvania 19102, Department of Chemistry, Bryn Mawr College, Bryn Mawr, Pennsylvania, Dana-Farber Cancer Institute, Division of AIDS, Harvard Medical School, Boston, Massachusetts 02115,... Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA; Department of Immunology and Infectious Disease, Harvard School of Public Health, Boston, Massachusetts, USA; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard, Boston, Massachusetts, USA Dana Farber Cancer Institute, Boston, Masssachusetts 02115 Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Boston, Massachusetts, USA; Department of Microbiology and Immunology, Harvard Medical School, Boston, Massachusetts, USA *Department of Cancer Immunology and AIDS, Dana–Farber Cancer Institute, Division of AIDS, Harvard Medical School, Boston, MA 02115;; Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, MA 02115 Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Microbiology and Immunobiology, Harvard Medical School, Boston, Massachusetts.; Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, Massachusetts. Department of Cancer Immunology/AIDS, Dana-Farber Cancer Institute, Department of Pathology, Division of AIDS, Harvard Medical School, Boston, Massachusetts Division of Human Retrovirology, Dana-Farber Cancer Institute, and Department of Pathology, Harvard Medical School,1 and; Department of Cancer Biology, Harvard School of Public Health,2Boston, Massachusetts 02115 Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, and Department of Pathology, Division of AIDS, Harvard Medical School; Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, Massachusetts 02115 Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA; Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA Department of Medicine, School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, Department of Cancer Immunology and AIDS, Dana Farber Cancer Institute, and Department of Pathology, Harvard Medical School, Boston, Massachusetts 02115, Department of Molecular Immunology, SmithKline Beecham, King of Prussia, Pennsylvania 19406, and Howard Hughes Medical Institute, Columbia University, New York, New York 10032 Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Avenue, Boston, Massachusetts 02115, United States; Department of Microbiology and Immunology, Harvard Medical School; Department of Immunology and Infectious Diseases, Harvard School of Public Health; Ragon Institute of MGH, MIT and Harvard, Boston, Massachusetts 02115, United States Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, and Division of AIDS, Harvard Medical School, Boston, Massachusetts Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, and Department of Microbiology and Immunobiology, Division of AIDS, Harvard Medical School, Boston, Massachusetts, USA; Ragon Institute of MGH, MIT and Harvard, Boston, Massachusetts, USA; Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, Massachusetts, USA Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Department of Microbiology and Immunobiology, Harvard Medical School, Boston, Massachusetts, USA; Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, Massachusetts, USA Department of Cancer Immunology & AIDS, Dana-Farber Cancer Institute,1; Department of Pathology2 and; Department of Immunology and Infectious Diseases, Harvard School of Public Health,4Boston, Massachusetts 02115 From the *Division of Human Retrovirology, Dana-Farber Cancer Institute, Department of Pathology, Harvard Medical School, Boston, Massachusetts 02115; ‡Department of Cancer Biology, Harvard School of Public Health, Boston, Massachusetts 02115; §Perlmutter Laboratory, Children's Hospital, and Department of Medicine and Department of Pediatrics, Beth Israel Hospital and Harvard Medical School, Boston, Massachusetts 02115; and ‖Institute of Microbiology, University of Padua Medical School, Padua, Italy 35121; From the *Division of Human Retrovirology, Dana-Farber Cancer Institute, Department of Pathology, Harvard Medical School, Boston, Massachusetts 02115; ‡Department of Cancer Biology, Harvard School of Public Health, Boston, Massachusetts 02115; §Perlmutter Laboratory, Children's Hospital, and Department of Medicine and Department of Pediatrics, Beth Israel Hospital and Harvard Medical School, Boston, Massachusetts 02115; and ‖Institute of Microbiology, University of Padua Medical School, Padua, Italy 35121 Department of Immunology and Infectious Diseases, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, USA; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA; Department of Microbiology and Immunobiology, Harvard Medical School, Boston, Massachusetts, USA Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115; Department of Immunology and Infectious Disease, Harvard School of Public Health, Boston, Massachusetts 02115 Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 021153; Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, and Department of Pathology, Harvard Medical School,2 and; Department of Immunology and Infectious Diseases, Harvard School of Public Health,4 Boston, Massachusetts 02115; and Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute,1; Department of Pathology, Harvard Medical School,2 and; Department of Immunology and Infectious Diseases, Harvard School of Public Health,3 Boston, Massachusetts 02115 Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Department of Pathology, Division of AIDS, Harvard Medical School and Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, Massachusetts 02115 Department of Infectious Disease Research, Southern Research Institute, Frederick, Maryland, USA Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Boston, Massachusetts 02115; Department of Pathology, Division of AIDS, Harvard Medical School, Boston, Massachusetts 02115; Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, Massachusetts 02115 Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute; Department of Microbiology and Immunobiology, Division of AIDS, Harvard Medical School, and Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, Massachusetts, USA; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard, Charlestown, Massachusetts, USA Vaccine Research Center, National Institute of Allergy and Infectious Diseases, Bethesda, MD 20892, USA.; Basic Research Program, SAIC-Frederick, Center for Cancer Research Nanobiology Program, National Cancer Institute, Frederick, MD 21702, USA.; Protein Interaction Group, Center for Cancer Research Nanobiology Program, National Cancer Institute, Frederick, MD 21702, USA.; Department of Molecular Biology and Skaggs Institute for Chemical Biology, Scripps Research Institute, La Jolla, CA 92037, USA.; Theoretical Biology (T10), Los Alamos National Laboratory, Los Alamos, NM 87545, USA. Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892; Department of Biochemistry and Molecular Biophysics and Howard Hughes Medical Institute, Columbia University, New York, NY 10032; Brigham and Women's Hospital, and Children's Hospital, Department of Pediatrics, Department of Medicine (Microbiology and Molecular Genetics), and Department of Cancer Immunology and AIDS, Dana–Farber Cancer Institute, and Department of... Department of Cancer Immunology and AIDS1 and; Department of Immunology and Infectious Diseases, Harvard School of Public Health,6Boston, Massachusetts 02115; Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute; Department of Pathology, Division of AIDS, Harvard Medical School, Boston, Massachusetts 02115; Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, Massachusetts 02115 R. Wyatt is in the Department of Cancer Immunology/AIDS, Dana-Farber Cancer Institute, Department of Pathology, Harvard Medical School, Boston, MA 02115, USA. J. Sodroski is in the Department of Cancer Immunology/AIDS, Dana-Farber Cancer Institute, Department of Pathology, Harvard Medical School, and Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, MA 02115, USA. Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, and Department of Microbiology and Immunobiology, Division of AIDS, Harvard Medical School, Boston, Massachusetts, USA; Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, Massachusetts, USA Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Harvard Medical School,2 and; Department of Immunology and Infectious Diseases, Harvard School of Public Health,3 Boston, Massachusetts 02115 Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute; Department of Pathology, Division of AIDS, Harvard Medical School; Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, Massachusetts 02115 Department of Pathology, Division of AIDS, Harvard Medical School; Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute; Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, Massachusetts 02215 Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Department of Pathology,1 and Perlmutter Laboratory, Children’s Hospital, and; Department of Immunology and Infectious Diseases, Harvard School of Public Health,2 Boston, Massachusetts 02115 Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Department of Microbiology, Harvard Medical School, Boston, Massachusetts, USA; Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, Massachusetts, USA Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Department of Pathology, Division of AIDS, Harvard Medical School, Boston, Massachusetts 02115; Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, Massachusetts 02115 Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, Massachusetts 02115, United States Dana Farber Cancer Institute3 and Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute,1; Departments of Pathology,2; Department of Immunology and Infectious Diseases, Harvard School of Public Health,5 Department of Cancer Immunology & AIDS, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA; Department of Immunology & Infectious Disease, Harvard School of Public Health, Boston, Massachusetts, USA; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard, Boston, Massachusetts, USA Dana-Farber Cancer Institute, Department of Pathology, Harvard Medical School, Boston, Massachusetts 02115 Department of Cancer Immunology and AIDS1 and; Dana-Farber Cancer Institute, Department of Pathology, Harvard Medical School,6 and; Department of Immunology and Infectious Diseases, Harvard School of Public Health,7 Boston, Massachusetts 02115; Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute,1 Harvard Medical School, and; Department of Immunology and Infectious Diseases, Harvard School of Public Health,5 Boston, Massachusetts 02115 Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Department of Microbiology, Harvard Medical School, Boston, MA, USA Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Boston, Massachusetts 02115.; Department of Pathology, Division of AIDS, Harvard Medical School, Boston, Massachusetts 02115.; Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, Massachusetts 02115. From the *Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115; the ‡Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, Massachusetts 02115; the §Division of Viral Pathogenesis, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02115; the ‖Department of Pathology and Korber Laboratory, Bernhard-Nocht Institute for Tropical Medicine, 20359 Hamburg, Germany; the ¶Department of Biostatistical Sciences, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115; the **Department of Medicine and Department of Pediatrics, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02115; the ††Institute of Microbiology, University of Padua Medical School, Padua 35121, Italy; and the §§Oregon Regional Primate Research Center, Beaverton, Oregon 97006-3499; From the *Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115; the ‡Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, Massachusetts 02115; the §Division of Viral Pathogenesis, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02115; the ‖Department of Pathology and Korber Laboratory, Bernhard-Nocht Institute for Tropical Medicine, 20359 Hamburg, Germany; the ¶Department of Biostatistical Sciences, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115; the **Department of Medicine and Department of Pediatrics, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02115; the ††Institute of Microbiology, University of Padua Medical School, Padua 35121, Italy; and the §§Oregon Regional Primate Research Center, Beaverton, Oregon 97006-3499 Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA. Department of Medicine, School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, and Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, and Department of Pathology, Harvard Medical School, Boston, Massachusetts 02115 Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Boston, Massachusetts4 1Department of Cancer Immunology & AIDS, Dana-Farber Cancer Institute; 2Department of Pathology, Division of AIDS, Harvard Medical School; 3Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, MA 02115 Dana Farber Cancer Institute, Boston, Massachusetts Department of Oncological Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT 84112; Departments of Immunology and Structural Biology, SmithKline Beecham Pharmaceuticals, King of Prussia, PA 19406; Department of Biochemistry and Molecular Biophysics and Howard Hughes Medical Institute, Columbia University, New York, NY 10032; and Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Department of Medicine, and Department of Pathology, Harvard Medical School,... Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute and Department of Microbiology and Immunobiology, Division of AIDS, Harvard Medical School, Boston, Massachusetts, USA; Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA Laboratory of Biochemical Pharmacology, Dana-Farber Cancer Institute, Boston, Massachusetts 02115; Department of Pathology, Harvard Medical School, Boston, Massachusetts 02115 Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute; Department of Pathology, Division of AIDS, Harvard Medical School; Department of Immunology and Infectious Diseases, Harvard School of Public Health Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Department of Pathology, Harvard Medical School,1 and; Department of Immunology and Infectious Diseases, Harvard School of Public Health,2 Boston, Massachusetts 02115 Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, and Department of Microbiology and Immunobiology, Division of AIDS, Harvard Medical School, Boston, Massachusetts, USA; Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, Massachusetts, USA; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard, Cambridge, Massachusetts, USA Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA; Department of Microbiology and Immunobiology, Division of AIDS, Harvard Medical School, Boston, Massachusetts, USA; Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, Massachusetts, USA; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard, Charlestown, Massachusetts, USA Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Harvard Medical School,1; Department of Immunology and Infectious Diseases, Harvard School of Public Health,2 and From *LeukoSite, Inc., Cambridge, Massachusetts 02142; ‡Aaron Diamond AIDS Research Center, The Rockefeller University, New York 10016; §Division of Human Retrovirology, Dana-Faber Cancer Institute, Department of Pathology, Harvard Medical School, Boston, Massachusetts 02115; and ‖Department of Cancer Biology, Harvard School of Public Health, Boston, Massachusetts 02115; From *LeukoSite, Inc., Cambridge, Massachusetts 02142; ‡Aaron Diamond AIDS Research Center, The Rockefeller University, New York 10016; §Division of Human Retrovirology, Dana-Faber Cancer Institute, Department of Pathology, Harvard Medical School, Boston, Massachusetts 02115; and ‖Department of Cancer Biology, Harvard School of Public Health, Boston, Massachusetts 02115 Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Department of Pathology, Division of AIDS, Harvard Medical School, Boston, MA 02115, USA.; Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, MA 02115, USA. Department of Cancer Immunology & AIDS, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115; Department of Immunology & Infectious Disease, Harvard School of Public Health, Boston, Massachusetts 02115 Department of Cancer Immunology and AIDS and Department of Biostatistical Science, Dana-Farber Cancer Institute, and Department of Pathology, Division of AIDS, Harvard Medical School, and Department of Biostatistics and Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, Massachusetts Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute,1 and; Department of Immunology and Infectious Diseases, Harvard School of Public Health,3 Boston, Massachusetts Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA; Department of Microbiology, Harvard Medical School, Boston, Massachusetts, USA; Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA Division of Human Retrovirology, Dana-Farber Cancer Institute, Department of Pathology, Harvard Medical School,1 and; Department of Cancer Biology, Harvard School of Public Health,2Boston, Massachusetts 02115; Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Department of Pathology, Division of AIDS, Harvard Medical School; Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, Massachusetts Department of Immunology and Infectious Diseases, Harvard T. H. Chan School of Public Health, Boston, 02215, MA, USA. Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, and Department of Pathology, Harvard Medical School,1 and; Department of Immunology and Infectious Diseases, Harvard School of Public Health,2 Boston, Massachusetts 02115 Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute,1; Department of Pathology2 and; Department of Immunology and Infectious Diseases, Harvard School of Public Health,4Boston, Massachusetts 02115 Human Retrovirology,3 Dana-Farber Cancer Institute, and; Pathology,4 Harvard Medical School, Boston, Massachusetts 02115 Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Department of Microbiology and Immunobiology, Harvard Medical School, Boston, Massachusetts, USA; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard Medical School, Boston, Massachusetts, USA; Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, Massachusetts, USA Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Department of Microbiology and Immunobiology, Harvard Medical School, Boston, Massachusetts, USA; Department of Immunology and Infectious Diseases, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, USA Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, and Department of Microbiology and Immunobiology, Harvard Medical School, Boston, Massachusetts, USA; Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, Massachusetts, USA Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, and Department of Pathology, Division of AIDS, Harvard Medical School, Boston, Massachusetts 02115; Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, Massachusetts 02115 Department of Cancer Immunology and AIDS; Department of Pathology, Division of AIDS, Harvard Medical School, Boston, Massachusetts 02115; Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, Massachusetts 02115 Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Department of Pathology, Division of AIDS, Harvard Medical School, and Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, Massachusetts 02115 Division of Human Retrovirology,6 Dana-Farber Cancer Institute, and; Harvard Medical School,2 Boston, Massachusetts 02115; Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, and Department of Microbiology and Immunobiology, Division of AIDS, Harvard Medical School, Boston, Massachusetts, USA; Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, Massachusetts, USA; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard, Boston, Massachusetts, USA Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA; Department of Microbiology and Immunobiology, Harvard Medical School, Boston, Massachusetts, USA; Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, Massachusetts, USA Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute; Department of Pathology, Division of AIDS, Harvard Medical School; Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, Massachusetts Laboratory of Biochemical Pharmacology, Dana-Farber Cancer Institute, Boston, MA 02115.; Department of Pathology, Harvard Medical School, Boston, MA 02115. Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA; Department of Microbiology and Immunobiology, Harvard Medical School, Boston, Massachusetts; Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, Massachusetts, USA Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, 1; Department of Pathology 2 and; Department of Immunology and Infectious Diseases, Harvard School of Public Health, 4 Boston, Massachusetts 02115, and Dana-Farber Cancer Institute, Boston, Massachusetts 02115 Department of Cancer Immunology and AIDS, Dana–Farber Cancer Institute, Division of AIDS, Harvard Medical School, Boston, MA 02115; Division of Molecular Medicine, Children's Hospital, Department of Genetics, Harvard Medical School, Boston, MA 02115; and Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, MA 02115 Division of Human Retrovirology, Dana-Farber Cancer Institute,1; Department of Pathology, Harvard Medical School,2; Department of Immunology and Infectious Diseases, Harvard School of Public Health,5 Boston, Massachusetts 02115 Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.; Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD 20892, USA.; Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA.; Department of Molecular Biology and Skaggs Institute for Chemical Biology, The Scripps Research Institute, La Jolla, CA 92037, USA.; Department of Pediatrics, Tulane University Medical Center, New Orleans, LA 70112, USA. |
Incoming Links
Total number of triples: 388.